Purpose: The study purpose was to pilot test a web-based human papillomavirus (HPV) vaccination intervention among young gay and bisexual men (YGBM). Methods: In 2016, we recruited 150 unvaccinated YGBM aged 18-25 years from the United States. We randomized participants to the Outsmart HPV intervention or a control group. Results: HPV vaccine initiation was higher among the intervention group than the control group (45% vs. 26%; odds ratio [OR] = 2.34, 95% confidence interval [CI]: 1.18-4.67). We observed a trend toward higher HPV vaccine completion among the intervention group (11% vs. 3%; OR = 4.24, 95% CI: 0.87-20.66). Conclusions: Outsmart HPV is a promising strategy for increasing HPV vaccination among YGBM.
Bibliographical noteFunding Information:
This study was supported by the National Cancer Institute of the National Institutes of Health under Award Number R21CA194831. This clinical trial is registered at Clinical-Trials.gov: identifier NCT02835755. We thank the Center for Health Communications Research at the University of Michigan for their contributions during the development and implementation of this intervention.
P.L.R. has received research grants from Merck Sharp & Dohme Corp. and Cervical Cancer-Free America, through an unrestricted educational grant from GlaxoSmithKline. E.D.P. has received research grants from Merck Sharp & Dohme Corp. These funds were not used to support this research study. None of the other authors have disclosures to report.
© Copyright 2018, Mary Ann Liebert, Inc.
- HPV vaccine
- sexual minority men